Audentes Therapeutics, Inc. announced earnings results for the fourth quarter ended December 31, 2018. For the fourth quarter, the company announced operating loss was USD 37.598 million compared to USD 26.881 million a year ago. Net loss was USD 35.592 million compared to USD 24.375 million a year ago. Basic loss per share was USD 0.84 compared to USD 0.82 a year ago. For the full year, operating loss was USD 134.372 million compared to USD 93.177 million a year ago. Net loss was USD 128.821 million compared to USD 90.238 million a year ago. Basic loss per share was USD 3.4 compared to USD 3.4 a year ago.